Latvia vs Slovak Republic: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Latvia
- Slovak Republic
How they compare
Latvia currently reports 46 Cases against 7 Cases in Slovak Republic, a difference of 39 Cases.
That makes Latvia's figure about 6.6 times Slovak Republic's.
Across all 20 years both countries report, Latvia has been ahead every year.
Latvia ranks 4th and Slovak Republic ranks 3rd of 7 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Slovak Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.8 Cases | 3.6 Cases | 95.2 Cases | Latvia |
| 2010s | 124.3 Cases | 6.4 Cases | 117.9 Cases | Latvia |
| 2020s | 48.6 Cases | 4.8 Cases | 43.8 Cases | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Latvia or Slovak Republic?
- Latvia, at 46 Cases against 7 Cases in Slovak Republic as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Latvia and Slovak Republic?
- 39 Cases, with Latvia ahead.
- How many years of comparable data are there for Latvia and Slovak Republic?
- 20 years are reported by both, from 2005 to 2024.
- How do Latvia and Slovak Republic rank globally for communicable diseases — communicable disease incidence?
- Latvia ranks 4th and Slovak Republic ranks 3rd of 7 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.